Title: Tóth G, et al. Targeting the intrinsically disordered structural ensemble of α-synuclein by small molecules as a potential therapeutic strategy for Parkinson's disease. PLoS One. 2014 Feb 14;9(2):e87133.
1494-84-4
1494-85-5
16504-19-1
1678-25-7
953717-92-5
312-52-7
33879-32-2 | 3-Methoxy-l-phenylalanine | AA007IHZ | MFCD00044954
33704-61-9 | 1,1,2,3,3-pentamethyl-2,3,4,5,6,7-hexahydro-1H-inden-4-one | AA007IXN | MFCD00216987
301164-69-2 | 1-(Thiophene-2-carbonyl)-1H-1,2,3-benzotriazole | AA007JFP | MFCD00583990
299-11-6 | Phenazine methosulfate | AA007JY1 | MFCD00011923
28342-75-8 | 1,5-Dibromo-2,4-difluorobenzene | AA007KNH | MFCD08458122
13788-92-6 | 1-(4-Bromophenyl)-1H-pyrazole | AA007L8C | MFCD08059318
28025-77-6 | 4-Morpholinepropanoicacid, hydrobromide (1:1) | AA007LQ5 | MFCD03452744
269731-55-7 | 4-Bromo-2-propoxybenzoic acid | AA007M6Z | MFCD11619323
24581-99-5 | Methyl 2-(4-bromo-2-formylphenoxy)acetate | AA007ML9 | MFCD02629616
133627-24-4 | N11-Cyclopropyl-4-hydroxymethyl-5,11-dihydro-6H-dipyrido(3,2-b:2,3-e)(1,4)diazepin-6-one | AA007N4Z